骨髓增生-话题@MedSci

#骨髓增生#

95篇内容 | 1058人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1821764, encodeId=bd321821e64e9, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=CLIN CANCER RES：Ipilimumab治疗低甲基化治疗失败的骨髓增生异常综合征患者, objectType=article, longId=146599, objectId=3dd2146599e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd2146599e1, replyNumber=0, likeNumber=40, createdTime=2019-05-08, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd2146599e1, moduleTitle=CLIN CANCER RES：Ipilimumab治疗低甲基化治疗失败的骨髓增生异常综合征患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dd2146599e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821756, encodeId=f1541821e5669, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, objectType=article, longId=139536, objectId=a6da1395367c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6da1395367c, replyNumber=0, likeNumber=30, createdTime=2018-09-13, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6da1395367c, moduleTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6da1395367c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821761, encodeId=52cb1821e6172, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=病例分享：一例少见类型骨髓增生异常综合征的诊断, objectType=article, longId=142917, objectId=ac8e14291ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac8e14291ed0, replyNumber=0, likeNumber=37, createdTime=2019-04-04, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac8e14291ed0, moduleTitle=病例分享：一例少见类型骨髓增生异常综合征的诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac8e14291ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821747, encodeId=78c31821e4780, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。, objectType=article, longId=126255, objectId=146e12625557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146e12625557, replyNumber=0, likeNumber=43, createdTime=2018-04-10, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146e12625557, moduleTitle=Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146e12625557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821762, encodeId=6aca1821e6213, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=NCCN临床实践指南：骨髓增生异常综合征（2019.V1）, objectType=article, longId=144865, objectId=7af814486562, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7af814486562, replyNumber=0, likeNumber=7, createdTime=2019-03-27, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7af814486562, moduleTitle=NCCN临床实践指南：骨髓增生异常综合征（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7af814486562)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821757, encodeId=4d1b1821e5732, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征, objectType=article, longId=140939, objectId=c0ea140939f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0ea140939f3, replyNumber=0, likeNumber=53, createdTime=2019-03-26, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0ea140939f3, moduleTitle=Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0ea140939f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821773, encodeId=b54c1821e73dc, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：树突细胞不能正常激活CD4 T细胞时可导致骨髓增生, objectType=article, longId=151666, objectId=20831516660f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20831516660f, replyNumber=0, likeNumber=28, createdTime=2019-03-05, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20831516660f, moduleTitle=Blood：树突细胞不能正常激活CD4 T细胞时可导致骨髓增生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20831516660f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821746, encodeId=13231821e4686, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。, objectType=article, longId=125270, objectId=b34b1252e09e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b34b1252e09e, replyNumber=0, likeNumber=28, createdTime=2018-07-20, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b34b1252e09e, moduleTitle=Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b34b1252e09e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821767, encodeId=16831821e67e9, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, objectType=article, longId=148690, objectId=adeb1486905b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adeb1486905b, replyNumber=0, likeNumber=23, createdTime=2018-09-20, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adeb1486905b, moduleTitle=Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adeb1486905b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821763, encodeId=3c401821e6358, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=骨髓增生异常综合征中西医结合诊疗专家共识（2018年）, objectType=article, longId=145202, objectId=eacc14520222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eacc14520222, replyNumber=0, likeNumber=11, createdTime=2019-03-07, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eacc14520222, moduleTitle=骨髓增生异常综合征中西医结合诊疗专家共识（2018年）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eacc14520222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821755, encodeId=08301821e55f6, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=NATURE：微生物信号驱动白血病前期骨髓增生, objectType=article, longId=138595, objectId=77c913859504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77c913859504, replyNumber=0, likeNumber=22, createdTime=2018-06-24, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77c913859504, moduleTitle=NATURE：微生物信号驱动白血病前期骨髓增生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77c913859504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821754, encodeId=d45e1821e5446, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, objectType=article, longId=135312, objectId=411e1353128b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411e1353128b, replyNumber=0, likeNumber=34, createdTime=2019-03-18, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411e1353128b, moduleTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411e1353128b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821760, encodeId=e35a1821e60f6, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, objectType=article, longId=141566, objectId=d1de1415660b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1de1415660b, replyNumber=0, likeNumber=31, createdTime=2018-10-14, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1de1415660b, moduleTitle=Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1de1415660b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821752, encodeId=e8081821e5294, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：如何治疗儿童骨髓增生异常综合征, objectType=article, longId=133741, objectId=7944133e4105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7944133e4105, replyNumber=0, likeNumber=37, createdTime=2019-02-05, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7944133e4105, moduleTitle=Blood：如何治疗儿童骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7944133e4105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821742, encodeId=91321821e425f, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, objectType=article, longId=106541, objectId=fee61065410a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee61065410a, replyNumber=0, likeNumber=26, createdTime=2018-05-12, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee61065410a, moduleTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee61065410a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821749, encodeId=c3c91821e499b, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, objectType=article, longId=127999, objectId=036712e999a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036712e999a7, replyNumber=0, likeNumber=34, createdTime=2018-09-13, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036712e999a7, moduleTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036712e999a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821753, encodeId=d6471821e5329, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后, objectType=article, longId=134407, objectId=1f4713440e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f4713440e66, replyNumber=0, likeNumber=29, createdTime=2018-10-26, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f4713440e66, moduleTitle=Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f4713440e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821739, encodeId=2bae1821e3973, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：骨髓增生异常综合征患者的SF3B1基因突变来源于淋巴性造血干细胞, objectType=article, longId=103074, objectId=1d9c1030e491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d9c1030e491, replyNumber=0, likeNumber=36, createdTime=2018-04-28, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d9c1030e491, moduleTitle=Blood：骨髓增生异常综合征患者的SF3B1基因突变来源于淋巴性造血干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d9c1030e491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821751, encodeId=aa731821e5182, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=NCCN临床实践指南：骨髓增生异常综合征（2018.V2）, objectType=article, longId=132589, objectId=3af8132589fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3af8132589fc, replyNumber=0, likeNumber=8, createdTime=2018-05-10, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3af8132589fc, moduleTitle=NCCN临床实践指南：骨髓增生异常综合征（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3af8132589fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821740, encodeId=910e1821e40c6, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关, objectType=article, longId=104465, objectId=b6041044659f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6041044659f, replyNumber=0, likeNumber=28, createdTime=2018-02-22, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6041044659f, moduleTitle=CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6041044659f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓增生

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

CLIN CANCER RES：Ipilimumab治疗低甲基化治疗失败的骨髓增生异常综合征患者

2019-05-08

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？

2018-09-13

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

病例分享：一例少见类型骨髓增生异常综合征的诊断

2019-04-04

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet haemat：Sotatercept，活性受体融合蛋白，治疗骨髓增生异常综合征患者的贫血的疗效和安全性。

2018-04-10

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

NCCN临床实践指南：骨髓增生异常综合征（2019.V1）

2019-03-27

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：造血干细胞Srsf2[P95H]突变启动髓系偏倚和骨髓增生异常/骨髓及髓外增生异常（MDS/MPN）综合征

2019-03-26

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：树突细胞不能正常激活CD4 T细胞时可导致骨髓增生

2019-03-05

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。

2018-07-20

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Haematologica：TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子

2018-09-20

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

骨髓增生异常综合征中西医结合诊疗专家共识（2018年）

2019-03-07

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

NATURE：微生物信号驱动白血病前期骨髓增生

2018-06-24

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估

2019-03-18

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Haematologica：研究发现TGFβ1是引起骨髓增生异常综合征和急性髓系白血病间充质干细胞的功能性抑制触发因子

2018-10-14

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：如何治疗儿童骨髓增生异常综合征

2019-02-05

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好

2018-05-12

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪

2018-09-13

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后

2018-10-26

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：骨髓增生异常综合征患者的SF3B1基因突变来源于淋巴性造血干细胞

2018-04-28

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

NCCN临床实践指南：骨髓增生异常综合征（2018.V2）

2018-05-10

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关

2018-02-22

科室
- - 订阅+
  - 更多科室
工具
服务